SNRS- Sunrise Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies

SNRS 0.000001000

0.0%

Jun 6 11:01 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BARRY ALLEN who wrote (2824)	7/29/1999 11:58:00 PM
From: BARRY ALLEN	Read Replies (2) of 4140

LTK Patient Update My first LTK patient came in today for his annual exam. I first examined him in June 1997. At that time he was a Hyperope with the following prescription data. Right Eye(R.E.) +1.75 -.050 axis 110. Left Eye(L.E.) +1.75 sphere. Near Vision ADD...+2.00 Uncorrected Visual acuity was 20/70. 9/97......LTK performed L.E. 3/98......LTK performed R.E. 7/29/99......Refraction yielded: R.E. Plano -.075 axis 105 (16 months post LTK) L.E. +.075 -.075 axis 80 (22 months post LTK) Near Vision ADD....+1.75 Uncorrected Visual acuity was 20/25! Summary...... R.E. +1.75 diopters Distance & +0.25 diopters Near = +2.00 diopters less correction after 16 months LTK! L.E.+1.75 diopters Distance(+0.75-0.75 axis 80 = effective plano) & +0.25 diopters Near = +2.00 diopters less correction after 22 months LTK! Uncorrected Visual Acuity......... 20/70--->20/25 = 5 lines better on the chart. Glasses not needed to pass vision test at motor vehicle department! Compare 16 months versus 22 months and you will notice virtual no change in refractive condition or "regression"! (No need for 24 month data!) It's a shame the ODP was not educated on this wonderful procedure. Actually they neglected their duties and fiduciary responsibility to the public by not witnessing the LTK procedure and interviewing patients. The FDA should be embarrassed by their panel's shameful performance. It is now Sunrise's obligation to educate the FDA!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next